Table 1.
Anticoagulation Regimen | Initial Bolus (U/kg) | Maximum Bolus (U) | Starting Infusion Rate | Goal aPTT (s) | Goal anti-Xa (IU/ml) | Maximum Infusion Rate |
Regional citrate ACD-A | None | N/A | 22.4 mmol/hr (200 ml/h) | N/A | N/A | 33.6 mmol/h (300 ml/h) |
Prefilter heparin | None | N/A | 200 U/h | None | None | 600 U/h |
Minimally intensive heparin | None | N/A | 12 U/kg per h | 39–54 | 0.3–0.5 | None |
Low-intensity heparin | 60 | 4000 | 12 U/kg per h | 39–69 | 0.3–0.5 | None |
High-intensity heparin | 80 | None | 18 U/kg per h | 39–69 | 0.3–0.7 | None |
ACD-A contains 3% citrate (112 mmol/L, dextrose-sodium-citrate-citric acid 2.45–2.2 g –800 mg/100 ml solution). Heparin formulation was 25,000 units (U)/500 ml 5% dextrose solution. Dialysate calcium concentration was 1.0–2.25 mEq/L with regional citrate and 2.5–3.0 mEq/L with heparin-based anticoagulation. aPTT, activated partial thromboplastin time; ACD-A, anticoagulant dextrose citrate solution-A; N/A, not applicable.